IP Library Granted Patent US 8,198,039
Granted Patent B2
US 8,198,039 · App. 12/204,407 · Granted Jun 12, 2012

Biosensors and related methods

Assignee: University of Pittsburgh—Of the Commonwealth System of Higher Education
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,198,039
App. No.
12/204,407
Granted
Jun 12, 2012
Kind
B2
Abstract

Provided herein are biosensors that comprise a biological signal source linked to a substrate by a peptide nucleic acid spacer and methods of use of the biosensor. In one embodiment, the biosensor is used to detect prostate-specific antigen.

Claims (25)

1. A biosensor electrode assembly comprising a metalized peptide nucleic acid or peptide spacer linked to a conductive substrate and an anti-prostate specific antigen (PSA) binding reagent bound to a redox tag comprising PSA linked to a redox enzyme.

2. The biosensor of claim 1 , in which the conductive substrate is gold.

3. The biosensor of claim 1 , wherein the redox enzyme is chosen from one of NADH peroxidase, glucose oxidase, alkaline phosphatase and horseradish peroxidase.

4. The biosensor of claim 1 , wherein the spacer comprises one or more metal-binding groups.

5. The biosensor of claim 4 , wherein the one or more metal-binding groups is chosen from one or more of pyridine, bipyridine, porphyrin, and hydroxyquinoline groups.

6. The biosensor of claim 4 , wherein the metal-binding group comprises a coordinated metal ion.

7. The biosensor of claim 1 , wherein the peptide nucleic acidspacer is linked to a nanoelectrode.

8. The biosensor of claim 7 , wherein the nanoelectrode is chosen from one or more of a nanowire of gold, copper, carbon, tin, silver, platinum, palladium, indium, tin oxide ITO or combinations thereof, a carbon nanotube, and a silicon nanotube.

9. A method of detecting or quantifying PSA in a sample comprising contacting the sample with a biosensor electrode assembly comprising a metalized peptide nucleic acid or peptide spacer linked to a conductive substrate and an anti-prostate specific antigen (PSA) binding reagent bound to a redox tag comprising PSA linked to a redox enzyme, and determining if, or the extent of which, a signal from the biological signal source is changed in the presence of the sample as indicative of the presence of PSA in the sample.

10. The method of claim 9 , wherein displacement of the redox tag by PSA in the sample alters electron transfer rates through the spacer.

11. The biosensor of claim 1 , wherein the conductive substrate is selected from the group consisting of an electrode, a nanoelectrode and a nanoelectrode needle.

12. The biosensor of claim 1 , comprising an anti-PSA binding reagent linked to a nanoelectrode by a metallized polypeptide.

13. The biosensor of claim 12 , wherein the anti-PSA binding reagent is bound to a redox tag comprising a PSA antigen linked to a redox enzyme.

14. The biosensor of claim 13 , wherein the redox enzyme is glucose oxidase.

15. The biosensor of claim 1 , comprising a plurality of metalized peptide nucleic acid or peptide spacers each linked to the conductive substrate and an anti-PSA binding reagent bound to a redox tag comprising PSA linked to a redox enzyme.

16. The method of claim 9 , wherein the redox enzyme is one of NADH peroxidase, glucose oxidase, alkaline phosphatase and horseradish peroxidase.

17. The method of claim 9 , wherein the redox enzyme is glucose oxidase.

18. The method of claim 9 , wherein the spacer comprises one or more metal-binding groups.

19. The method of claim 18 , wherein the one or more metal-binding groups is selected from the group consisting of pyridine, bipyridine, porphyrin, and hydroxyquinoline groups.

20. The method of claim 18 , wherein the metal-binding group comprises a coordinated metal ion.

21. The method of claim 9 , in which the conductive substrate is gold.

22. The method of claim 9 , wherein the spacer is linked to a nanoelectrode.

23. The method of claim 22 , wherein the nanoelectrode is selected from the group consisting of one or more of a nanowire of gold, copper, carbon, tin, silver, platinum, palladium, indium tin oxide (ITO) or combinations thereof, a carbon nanotube, and a silicon nanotube.

24. The method of claim 9 , the biosensor electrode assembly comprising a plurality of metalized peptide nucleic acid or peptide spacers each linked to the conductive substrate and an anti-prostate serum antigen binding reagent bound to a redox tag comprising prostate serum antigen (PSA) linked to a redox enzyme.

25. The method of claim 9 , in which the conductive substrate is selected from the group consisting of an electrode, a nanoelectrode and a nanoelectrode needle.

Assignments (3)
CONFIRMATORY LICENSE Recorded Aug 17, 2010
From: UNIVERSITY OF PITTSBURGH
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 024849/0185 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 12, 2009
From: SHI, HAIBIN; YEH, JOANNE I
To: UNIVERSITY OF PITTSBURGH-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION
Reel/Frame 023506/0547 →
CONFIRMATORY LICENSE Recorded Apr 27, 2009
From: UNIVERSITY OF PITTSBURGH
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 022606/0247 →
Continuity (2)
Provisional Application 60969864 · Sep 4, 2007
Related Publication 20090061451A1 · Mar 5, 2009